Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06979154 · ClinicalTrials.gov registry record · NA
Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS)
A NA study of Major Depressive Disorder and Healthy (Controls), sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06979154: Recruiting NA study of Major Depressive Disorder and Healthy (Controls), sponsored by University of North Carolina, Chapel Hill.
NCT06979154 is a NA study of Major Depressive Disorder and Healthy (Controls) that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 10 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06979154, a NA study of Major Depressive Disorder and Healthy (Controls), is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop the safety, feasibility, and tolerability of a personalized transcranial alternating current stimulation (tACS) approach in antenatal depression.
Primary Outcome
The number of serious adverse events reported in healthy control and antenatal depression groups.
Conditions Studied
Interventions
- DEVICE tACS (aperiodic)
Study Locations (1)
North Carolina
- Carolina Center for Neurostimulation - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-08-12 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT06979154 shows while recruiting
NCT06979154 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which tACS (aperiodic) is the first listed.
NCT06979154 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06979154 about?
NCT06979154 is a clinical study titled "Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS)". The purpose of this study is to develop the safety, feasibility, and tolerability of a personalized transcranial alternating current stimulation (tACS) approach in antenatal depression.
What is the current status of trial NCT06979154?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-08-12. Estimated completion is 2026-12-01.
What conditions does trial NCT06979154 study?
This clinical trial studies the following conditions: Major Depressive Disorder, Healthy (Controls), Antenatal Depression, Major Depressive Disorder in Pregnancy.
What interventions are being tested in trial NCT06979154?
The interventions under investigation include: tACS (aperiodic) (DEVICE).
Who is sponsoring clinical trial NCT06979154?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06979154 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06979154's enrollment target sits among peer trials
10 272nd of 282 higher than 5 of 282 other Major Depressive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI